Plasma Therapy Market Size, Trends & Growth Opportunity, Type (Pure Platelet-Rich Plasma, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin), Application (Orthopaedics, Dermatology, Dentistry, and Others), and End User (Hospitals, Dermatology Clinics, and Others), Region and forecast till 2027.
Report ID : QR1001422 | Industries : Healthcare | Published On :January 2022 | Page Count : 232Plasma Therapy Market
Plasma therapy is a traditional method widely used in the fields of dentistry, dermatology and orthopedics. Plasma therapy is widely used in wound healing, androgenetic alopecia and facial rejuvenation. The plasma is concentrated to 3 to 5 times the physiological value and then injected into tissues where healing is needed. In addition, convalescent plasma therapy can be administered to people with COVID19 who are hospitalized and at an early stage of their disease, further driving the growth of plasma therapy market.
Drivers: Rise in prevalence of life-threatening diseases
Growth of the global plasma therapy market is majorly driven by rise in prevalence of life-threatening diseases, which includes various neurological system disorders such as chronic inflammatory demyelinating polyneuropathy (CIPD), idiopathic thrombocytopenic purpura (ITP), and multifocal motor neuropathy (MMN).
Know more about this report: request for sample pages
Restraints: High cost of Plasma Therapy
The high cost of plasma therapy is expected to hinder the market growth. The price of plasma extraction from the blood and its storage of extracted plasma are restricting the market growth. The price of therapy has restricted its use in underdeveloped and developing regions. Since the common person is not able to afford the therapy, this is one of the key factors restricting market growth.
Impact of COVID-19
The outbreak of COVID-19 has disrupted workflows in the healthcare sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of healthcare. Moreover, COVID-19 has positively impacted the plasma therapy market. On August 23, 2020, the FDA issued an emergency use authorization (EUA) for COVID-19 convalescent plasma for treatment of hospitalized patients with COVID-19 disease. Moreover, in March 2020, the Houston Methodist Hospital, U.S., announced that it was used plasma fractionation in the treatment of COVID-19. It became the first hospital in the U.S. to make use of plasma fractionation products in the fight against coronavirus disease pandemic.
Plasma from the blood of a patient who recovered from the COVID-19 was used for treatment of another patient suffering from COVID-19. Convalescent plasma can potentially develop as an effective treatment option to battle against the pandemic. Thus, rise in demand for plasma derived immunoglobulins for treatment procedures for COVID-19 patients with autoimmune and inflammatory disorders, which is anticipated to drive growth of the plasma fractionation market for immunoglobulin.
Segmentation By Type:
Depending on type, the market is bifurcated into pure platelet-rich plasma, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich fibrin. By type, the pure PRP segment is estimated to account for the largest share of the global plasma therapy market in 2020, owing to effective results of pure PRP therapy. Furthermore, rise in funding for health care and increase in use of PRP in hospitals and clinics propels the market. The pure platelet-rich segment is also set to have a healthy growth, owing to increased usage and antimicrobial effects.
Segmentation By End User:
On the basis of end user, it is segregated into hospitals, dermatology clinics, and others.
Segmentation By Application:
The application segment is further categorized into orthopedics, dermatology, dentistry, and others. On the basis application, the orthopedic segment accounted for the largest share in 2020, owing to increase in occurrences of orthopedic disorders such as arthritis and rise in healthcare expenditure.
Segmentation by Region
Based on region, the NGS services market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is projected to account for a major share of the global plasma therapy market during the forecast period. The market in the region is anticipated to grow in the future, owing to rise in research and developments made by government and private sectors. Asia-Pacific is also set to have a considerable growth, owing to increase in population and rise in awareness for blood donation. Increase in number of hospitals and clinics and presence of advanced plasma therapies propels the plasma therapy market growth.
Competitive Landscape:
The key players for the market are MTF Biologics, Regen Lab SA, Arthrex, Zimmer Biomet,and Pfizer Inc. .
Industrial Development:
In March 2020, the EMCYTE group acquired CELLMEDIX Holdings, which also includes the Centrepid Platelet Concentrator System. The following acquisitions now allow former access over several patents such as US 7,829,022 B1; US 9,718,003 B1 and US 10,040,064. Moreover, the access over the former patents will now allow the company to follow innovative strategies and expand its line of business towards biological creativity.
Market taxonomy
By Type
-
- Pure Platelet-rich plasma (PRP)
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
By Application
-
- Orthopedics
- Dermatology
- Dentistry
- Others
By End User
-
- Hospitals
- Dermatology Clinics
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Plasma Therapy Market Outlook TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Plasma Therapy Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Plasma Therapy Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Plasma Therapy Market Share Analysis, By Type
5.3 Plasma Therapy Market Size and Forecast, By Type
5.3.1 Pure Platelet-rich plasma (PRP)
5.3.2 Leukocyte-Rich PRP
5.3.3 Pure Platelet-Rich Fibrin
5.3.4 Leukocyte-Rich Fibrin
6 Plasma Therapy Market, By End-User
6.1 Y-o-Y Growth Comparison, By End-User
6.2 Plasma Therapy Market Share Analysis, By End-User
6.3 Plasma Therapy Market Size and Forecast, By End-User
6.3.1 Hospitals
6.3.2 Dermatology Clinics
6.3.3 Others
7 Plasma Therapy Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Plasma Therapy Market Share Analysis, By Application
7.3 Plasma Therapy Market Size and Forecast, By Application
7.3.1 Orthopedics
7.3.2 Dermatology
7.3.3 Dentistry
7.3.4 Others
8 Plasma Therapy Market, By Region
8.1 Plasma Therapy Market Share Analysis, By Region
8.2 Plasma Therapy Market Size and Forecast, By Region
9 North America Plasma Therapy Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 North America Plasma Therapy Market Share Analysis, By Type
9.3 North America Plasma Therapy Market Size and forecast, By End-User
9.4 North America Plasma Therapy Market Size and forecast, By application
9.5 North America Plasma Therapy Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Plasma Therapy Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Europe Plasma Therapy Market Share Analysis, By Type
10.3 Europe Plasma Therapy Market Size and Forecast, By End-User
10.4 Europe Plasma Therapy Market Size and forecast., By Application
10.5 Europe Plasma Therapy Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Plasma Therapy Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Asia Pacific Plasma Therapy Market Share Analysis, By Type
11.3 Asia Pacific Plasma Therapy Market Size and Forecast, by End-User
11.4 Asia Pacific Plasma Therapy Market size and forecast, By Application
11.5 Asia Pacific Plasma Therapy Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Plasma Therapy Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Latin America Plasma Therapy Market Share Analysis, By Type
12.3 Latin America Plasma Therapy Market Size and Forecast, By End-User
12.4 Latin America Plasma Therapy Market Size and Forecast, By application
12.5 Latin America Plasma Therapy Market Size and Forecast, Country
12.5.1. Brazil
12.5.2. Rest of Latin America
13 Middle East Plasma Therapy Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Middle East Plasma Therapy Market Share Analysis, By Type
13.3 Middle East Plasma Therapy Market Size and forecast, by End-User
13.4 Middle East Plasma Therapy Market Size and Forecast, by Application
13.5 Middle East Plasma Therapy Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4 Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 MTF Biologics
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Regen Lab SA
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Arthrex, Terumo Corporation
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Zimmer Biomet.
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Pfizer Inc.
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies